Cardinal Health (CAH)
Distributes pharmaceuticals and manufactures medical products for healthcare providers.
$222.93
vs last close+0.89 (+0.40%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54,650 | 57,442 | 54,868 | 59,708 | 52,277 | 55,264 | 54,878 | 60,159 | 64,009 | 65,441 | 60,940 | 63,858 |
| Cost of revenue | 52,907 | 55,588 | 52,933 | 57,855 | 50,375 | 53,323 | 52,755 | 57,957 | 61,690 | 63,230 | 58,442 | 61,112 |
| Gross profit | 1,743 | 1,846 | 1,935 | 1,853 | 1,902 | 1,941 | 2,123 | 2,202 | 2,319 | 2,211 | 2,498 | 2,746 |
| 1,775 | 1,349 | 1,566 | 1,445 | 1,334 | 1,392 | 1,393 | 1,774 | 1,651 | 1,504 | 1,989 | 2,017 | |
| 1,186 | 1,268 | 1,269 | 1,238 | 1,277 | 1,306 | 1,315 | 1,484 | 1,461 | 1,504 | 1,542 | 1,625 | |
| Selling & marketing | 0 | 0 | 0 | 1,238 | 1,277 | 1,306 | 1,315 | 1,484 | 1,461 | 1,504 | 1,542 | 1,625 |
| Other expenses | 589 | 81 | 297 | 207 | 57 | 86 | 78 | 290 | 190 | 0 | 447 | 392 |
| Operating income | −32 | 505 | 369 | 408 | 568 | 549 | 730 | 428 | 668 | 707 | 509 | 729 |
| −12 | 7 | −27 | −12 | −27 | −38 | −65 | −44 | −70 | −77 | −117 | −175 | |
| Interest expense | 11 | 3 | 28 | 4 | 32 | 35 | 74 | 74 | 80 | 88 | 101 | 79 |
| Other non-operating income | 1 | −10 | −1 | 16 | −5 | 3 | −9 | −30 | −10 | 165 | 16 | −80 |
| Income before tax | −44 | 512 | 342 | 396 | 541 | 511 | 665 | 384 | 598 | 630 | 392 | 554 |
| Income tax expense | −33 | 143 | 80 | 162 | 124 | 110 | 157 | 141 | 144 | 159 | 12 | 154 |
| Net income from continuing operations | −11 | 369 | 262 | 234 | 417 | 401 | 508 | 243 | 454 | 471 | 380 | 400 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | −4 |
| Net income | −12 | 368 | 261 | 236 | 416 | 400 | 506 | 239 | 450 | 471 | 399 | 394 |
| EPS, basic | −$0.05 | $1.50 | $1.07 | $0.96 | $1.71 | $1.65 | $2.11 | $1.00 | $1.89 | $1.98 | $1.69 | $1.71 |
| EPS, diluted | −$0.05 | $1.50 | $1.07 | $0.96 | $1.70 | $1.65 | $2.10 | $1.00 | $1.88 | $1.97 | $1.69 | $1.69 |
| Weighted average shares, basic | 249 | 245 | 243 | 244 | 243 | 242 | 240 | 239 | 238 | 236 | 235 | 236 |
| Weighted average shares, diluted | 250 | 246 | 245 | 245 | 245 | 243 | 241 | 240 | 239 | 237 | 236 | 237 |
| EBITDA | 139 | 690 | 547 | 578 | 755 | 738 | 946 | 667 | 911 | 707 | 741 | 1,119 |
| Depreciation & amortization | 172 | 175 | 177 | 186 | 182 | 192 | 207 | 209 | 233 | 165 | 248 | 310 |
| EBIT | −33 | 515 | 370 | 392 | 573 | 546 | 739 | 458 | 678 | 542 | 493 | 809 |
